Ethan Allen CEO on Tariffs, US Manufacturing, and Housing Market Impact

Navigating Tariff Uncertainties

• 🇺🇸 Ethan Allen manufactures approximately 75% of its furniture in North America, with nearly half produced in the US, providing a unique advantage against potential tariffs.
• 💡 The company made a strategic decision 20-30 years ago to invest in and maintain manufacturing in North America, rather than offshoring.
• ⚠️ For the 25% of products sourced internationally (accessories, textiles, some furniture), Ethan Allen is considering sharing costs with overseas partners and implementing price increases.

Manufacturing Strategy and Talent

• 🏭 Ethan Allen has consolidated its US manufacturing from 22 plants to more efficient facilities in Vermont and North Carolina, complemented by operations in Mexico and Honduras.
• 🧠 The company emphasizes combining advanced technology with skilled talent to maintain high quality across all manufacturing locations.
• 📈 A significant shift has occurred, with nearly 100% of North American-made products now being custom-made, compared to 70-80% custom orders 20 years ago.

Impact of Housing Market Slowdown

• 📉 A drop in store traffic (20-30% decrease) has been observed due to the slow housing market.
• 🤝 Despite lower traffic, the business has seen an increase due to strong relationships built by interior designers with existing clients, leading to repeat business.
• 🏠 Newer clients and some existing ones are holding back on purchases, indicating a cautious consumer sentiment tied to the housing market.

Labor and Healthcare Costs in US Manufacturing

• 🤖 Over the last five years, Ethan Allen has reduced its US manufacturing headcount by over 35% through technology adoption, mitigating labor shortages and the impact of fewer people entering the country.
• 🏥 Medical costs in the United States are highlighted as a significant and often overlooked challenge for manufacturers, with extreme costs for single cases compared to other countries.
• 🗣️ The CEO urges government leaders to focus on addressing the disaster of US medical costs to support domestic manufacturing.